Drug Shortage Report for PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION

Last updated on 2018-10-11 History
Report ID 29438
Drug Identification Number 02370174
Brand name PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN/TAZOBACTAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 4G 0.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-16
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-10-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-10-11 French Compare
v10 2018-10-11 English Compare
v9 2018-03-07 French Compare
v8 2018-03-07 English Compare
v7 2018-03-07 French Compare
v6 2018-03-07 English Compare
v5 2018-01-03 French Compare
v4 2018-01-03 English Compare
v3 2017-11-17 English Compare
v2 2017-11-16 French Compare
v1 2017-11-16 English Compare

Showing 1 to 11 of 11